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The response of growth hormone to acute exercise has been shown to be altered by 
training. The present study examined the time course of GH adaptation to 3-weeks of 
sprint exercise training on a cycle ergometer.  Eight, recreationally active, male subjects 
(age = 26.8 ± 4.3 yrs; height = 1.77 ± 0.05 m; weight = 77.79 ± 7.35 kg; lean body mass 
= 62.0 ± 7.1 kg) completed a 2-hour resting profile and a 2-hr acute sprint profile, 
followed by three weeks of training with additional acute sprint tests at the end of each 
week.  Blood samples were taken every 15 minutes [Q15] during rest and more 
frequently [Q1-Q10] during exercise. Body composition was assessed by DXA [Prodigy 
Advanced, GE Lunar]. Training consisted of 4-6 repetitions of 30-second maximal 
sprints relative to body mass, three times per week.  Integrated 2 hr serum GH area under 
the curve (AUC) was calculated using trapezoidal integration.  Peak power (PP) 
increased 7.5% while time to peak power (TTP) decreased 58.0 % (P < 0.05) over the 3-
week training period.  The mean of 2 hr GH AUC per unit lean body mass (LBM), did 
not significantly decrease (P = 0.82) during the 3-week sprint training protocol, although 
a trend was observed for GH AUC to decrease from the first acute sprint test to the 
second acute sprint test (8.45 ± 3.0 ng/ml vs. 3.59 ± 1.21 ng/ml, respectively; P = 0.90).  
While this trend was similar to previously reported findings, we conclude that 3-weeks of 
sprint training does not significantly alter the GH AUC response to acute sprint exercise 
despite significant increases in power output during this same time frame. 
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CHAPTER I 
 
INTRODUCTION 
 
 
Background 
 
 Human growth hormone (hGH) is a peptide hormone secreted from the anterior 
pituitary gland.  GH is not one single hormone, it is in fact a family of over 100 different 
molecules all sharing similar characteristics (Wideman, Weltman et al. 2002).  GH is 
secreted in a pulsatile fashion with the highest concentrations occurring after sleep and 
exercise, if the exercise is of adequate intensity and duration (Godfrey, 2003; Sutton, 
1976).  The exact mechanisms that elevate GH release in response to exercise are not 
known, however it is thought that it may be a result of; direct neural stimulation, 
feedback from circulating insulin-like growth factors (IGF), circulating catecholamines, 
blood lactate, nitric oxide (NO), and/or blood pH changes (mainly H
+
 ion accumulation) 
(Godfrey, 2003; Gordon, 1994).  GH release also acts as a glucose sparing agent by 
increasing free fatty acid concentration (FFA) in the blood (Quabbe, 1972).  In addition 
to having an effect on substrate utilization, GH release has also been proposed to inhibit 
protein catabolism and lead to muscle hypertrophy and tissue remodeling in response to 
exercise (Godfrey, 2003; Kraemer, 2005). 
 Previous research (Stokes, Nevill et al. 2004) showed that after 6 weeks of 
supervised sprint training a decrease in peak GH of over 40% was seen (10.3 ± 3.3 vs. 5.8 
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± 2.5 μg/l; P < 0.05) while no changes were seen in a group of control subjects.  We 
believe this may occur earlier than 6 weeks much like the muscle metabolic adaptations 
that have occurred in other sprint training studies (Burgomaster, Hughes et al. 2005; 
Gibala, Little et al. 2006).  Burgomaster and colleagues (2005) found that 6 sessions of 
sprint training with 1-2 rest days  between each session  significantly increased peak 
power output during the 6
th
 training session  (P < 0.05) compared to the first training 
session (Burgomaster, Hughes et al. 2005).  In the same study sprint training showed an 
increased endurance capacity but no increases in VO2peak. 
Similar to most training studies, we expect sprint performance to improve over 
the three week training program.  We also believe there will be an altered growth 
hormone response to sprint training.  Therefore the purpose of this study is twofold; first 
to identify the characteristics (magnitude, duration etc), of the altered growth hormone 
release in  response to sprint exercise training and secondly, to measure the time course 
of this adaptation to sprint exercise training. 
 
Specific Aims 
1. To determine the time course of a 3-week sprint training protocol on the acute 
growth hormone response to a single maximal 30-second sprint.  
2. To the time course peak power output and VO2max changes from baseline to the 
end of the 3-week sprint training protocol.  
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Hypotheses 
1. There will be a significant attenuation in peak growth hormone concentration in 
response to an acute maximal 30-second sprint after sprint training. 
a. A significant attenuation of peak growth hormone concentration in 
response to acute sprint exercise will not be observed after 1 week of 
sprint training. 
b. A significant attenuation of peak growth hormone concentration in 
response to acute sprint exercise will not be observed after 2 weeks of 
sprint training. 
c. A significant attenuation of peak growth hormone concentration in 
response to acute sprint exercise will be observed after 3 weeks of sprint 
training. 
2. There will be a significant attenuation in growth hormone area under the curve 
(AUC) in response to an acute maximal 30-second sprint after sprint training. 
a. A significant attenuation of growth hormone AUC in response to acute 
sprint exercise will not be observed after 1 week of sprint training. 
b. A significant attenuation of growth hormone AUC in response to acute 
sprint exercise will not be observed after 2 weeks of sprint training. 
c. A significant attenuation of growth hormone AUC in response to acute 
sprint exercise will be observed after 3 weeks of sprint training. 
3. Three weeks of sprint training will significantly increase peak power output 
compared to baseline.  
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4. It is not expected that a significant increase in VO2peak compared to baseline 
after 3-weeks of spring training will occur.
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CHAPTER II 
REVIEW OF THE LITERATURE 
 
 The purpose of this section is to review the previously reported literature on 
growth hormones and sprint exercise that used cycling as the modality. This section 
includes reviews on; growth hormone release during exercise, factors affecting GH 
release during exercise, the role of GH after exercise, acute sprint cycle exercise and 
sprint training.   
Overall Health Implications 
 GH has been linked to many health related benefits, those of which are absent in 
those whom are GH deficient.  Patients exhibiting GH deficiency in conditions such as 
hypothalamic or pituitary disease experience decreased lean muscle mass, increased body 
fat (especially abdominal obesity), reduced exercise capacity, insulin resistance, 
dyslipidemia, and impaired heart function (Wideman, Weltman et al. 2002).  GH 
administration in deficient adults resulted in lean muscle mass increases, fat mass 
decreases, reduced abdominal obesity, along with an increase in exercise capacity.  Age 
and body composition are also important determinants in GH production.  GH production 
and release decreases approximately 14% per decade after the age of 40 (Wideman, 
Weltman et al. 2002).  Many of the same conditions apparent in GH deficient individuals 
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are also present in the aging population.  GH administration to older adults has been 
reported to result in the same changes that occur in the GH deficient population 
(Wideman, Weltman et al. 2002).   
Growth Hormone and Exercise 
 
 Sutton and Lazarus (1976) attempted to validate the efficacy of exercise as a 
stimulus for the release of endogenous GH, by comparing exercise to pharmacological 
stimuli known to increase GH release.  The exercise stimuli included 20 minutes of 
constant load cycling on a cycle ergometer at 300 (25-33%), 600 (40-66%), and 900 
kpm/min (75-90% of VO2max).  Other stimuli used to induce GH release were arginine, 
L-DOPA, insulin hypoglycemia, and sleep.  The highest GH elevations were obtained 
following the most intense exercise with GH concentrations reaching 35.1 ± 6.3 ng/ml 
after 900 kpm/min of exercise, similar to the GH concentrations attained w ith insulin 
induced hypoglycemia (36.0 ± 5.0 ng/ml).  Low intensity exercise was not sufficient to 
produce pronounced elevations in GH leading investigators to theorize that a minimum 
intensity threshold may need to be reached to produce significant GH elevations in the 
blood (Viru 1985).  Thus, using exercise as a stimulator for GH release gives 
practitioners a safer alternative to measure the pituitary reserve of GH in deficient 
patients than insulin induced hypoglycemia, assuming an appropriately quantified 
exercise intensity and duration can be prescribed (Sutton and Lazarus 1976).   
Role of Exercise Intensity & Duration  
 Prior to work by Pritzlaff and colleagues (1999); debate still existed about the role 
intensity played in the release of GH during acute exercise, since previous research 
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suggested that a ‘threshold of intensity’ was likely required to significantly increase GH 
release (Sutton and Lazarus 1976; Felsing, Brasel et al. 1992; Pritzlaff, Wideman et al. 
1999).  Pritzlaff and colleagues examined the impact of exercise intensity on exercise 
induced GH release, and hypothesized that there would be an attenuation in GH release 
until lactate threshold (LT) was reached.  Constant load exercise was performed for 30 
minutes at 5 different exercise intensities [2 below, 2 above and one at LT].  Results 
indicated that GH release increased with increasing exercise intensity.  However, an 
exercise induced GH response occurred prior to LT, in opposition to what the authors had 
postulated.  Therefore, it appears that there is a direct linear relationship between exercise 
intensity and the growth hormone response (Pritzlaff, Wideman et al. 1999), and a 
threshold for GH release at the lactate threshold as postulated by Felsing (Felsing, Brasel 
et al. 1992) does not appear to be substantiated.  
 
Table 1.  GH response to submaximal endurance exercise 
 
Study Participants Method Effect on Acute GH release (µg/l) 
Wideman et al. (2006) Men (27 ± 4) Cycling 70% 
VO2peak 
30, 60, or 120 min 
Peak GH (13.3 ± 1.3, 22.4 ± 5.3, 
24.3 ± 5.3) 
 
 
 
Role of Growth Hormone after Exercise 
 Pritzlaff and colleagues (2000) examined the role GH and catecholamines play in 
substrate utilization during and after exercise.  The researchers followed up on previous 
studies indicating a shift in substrate utilization to fat oxidation post-exercise (Wolfe, 
1990; Bahr, 1991). Subjects exercised for 30 minutes at intensities of 25 and 75% of the 
difference between O2 uptake at rest and at LT, LT, and 25 and 75% of the difference 
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between O2 uptake at LT and VO2peak.  During recovery, fat expenditure increased with 
each increase in exercise intensity as did both peak GH and integrated GH concentration 
(IGHC).  Regression analysis for each subject revealed a statistically significant 
relationship between recovery fat oxidation and both peak GH and IGHC.  The results of 
their study infer that as the intensity of exercise increased so does the post-exercise fat 
oxidation, peak [GH], and IGHC.  This suggests that GH may be partially responsible for 
utilizing more fat from adipose tissue after exercise and preventing post-exercise 
hypoglycemia (Pritzlaff, 2000).  
 Enevoldsen and colleagues (2007) examined the role GH plays in post-exercise 
fat oxidation by inhibiting GH release through octreotide infusion.  Subjects came into 
the lab fasted and were studied for one hour at rest, one hour after beginning octreotide 
infusion, during one hour of treadmill running at 50% VO2max, and for four hours post-
exercise.  Adipose tissue glycerol and FFA output increased during exercise in both 
control and octreotide groups and returned to baseline levels within 60 minutes of 
cessation of exercise.  Arterial GH concentration increased with exercise in the control 
group only, reaching peak values about 30-45 minutes into exercise and decreasing 
steadily after cessation of exercise until baseline levels were re-established at 60 minutes 
post-exercise.  An increase was seen in adipose tissue glycerol and FFA release 
beginning at 60 minutes post-exercise and this time delay for increased FFA oxidation 
was also noted in other studies (Gravholt, Schmitz et al. 1999; Hansen, Gravholt et al. 
2002; Moller, Gjedsted et al. 2003; Djurhuus, Gravholt et al. 2004; Enevoldsen, Polak et 
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al. 2007).  This article supports the idea that GH is involved in the enhanced fat-oxidation 
observed in the post-exercise recovery period (Enevoldsen, Polak et al. 2007). 
Sprint Exercise 
 
 Stokes and colleagues (2002a) considered the role exercise duration plays in the 
GH response to a single bout of maximal sprint cycle exercise.  They examined the  
duration of the GH response after 6 and 30 seconds of maximal cycling exercise using a  
 
Table 2.  Summary of GH response to acute sprint cycling 
 
Study  Subjects Exercise  Effect on Acute GH release 
Stokes 
(2002a) 
9 health males  
23 (1) yrs 
6s and 30s, 7.5% of 
body weight 
30s sprint resulted in GH peak of 18.5 ± 3.1 µg·l
-1
 
GH AUC of 1808 ± 90 µg·l
-1
 
Stokes 
(2002b) 
10 healthy males 
24.5 (1.1) yrs 
30s maximal sprint at 
either 7.5% (fast) 
or10% (slow) 
pedaling rates 
Peak [GH] was higher in the fast trial vs. the slow trial 
(40.8 ± 8.2 vs. 20.8 ± 6.1 mU/l respectively; P < 0.05)  
 
GH AUC for fast vs. slow was also significant (1,697 ± 
367 vs. 933 ± 306 min·mU
-1
·l
-1
; P = 0.05) respectively 
Stokes 
(2003) 
11 healthy males 
24.6 (3.7) yrs 
examined 
reproducibility of 
GH response to 30s 
sprint on cycle 
ergometer.  
no significant difference in mean GH concentrtion or 
mean power output between trials. 
725 ± 84 vs. 721 ± 84 W between the first and second 
trial respectively 
GH AUC 270.9 ± 296.7 vs 273.8 ± 285.5 min·µg·l
-1
 
respectively 
Stokes 
(2005) 
8 healthy males 
23 (2) yrs 
30s maximal sprint 
against 7.5% of body 
weight with either 60 
or 240 min of rest 
For first sprint Peak GH of 14.4 ± 9.6 µg/l 
60 min GH AUC 460 ± 348 min·µg·l
-1 
 
 
resistance equivalent to 7.5% of the subject’s body mass.  There were no differences 
between the power outputs of the participants in the first 6s of either the 6s or 30s trials.  
Serum GH concentrations were elevated after both trials, however the magnitude of the 
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elevation after the 30s sprint was much greater than the 6s sprint.  Serum GH peaked at 
40 min post exercise in both trials and remained elevated for 60 min after the 6s sprint 
and 90-120 min after the 30s sprint.  The 30s sprint produced elevations in GH to 18.5 ± 
3.1 μg/l at peak, an increase of 530% from baseline, whereas the 6s sprint produced a GH 
concentration of only 4.0 ± 1.5 μg/l at peak concentration or 217% above baseline 
concentration.  This represented a 450% greater maximal GH concentration during the 
30s vs. the 6s trial.  The results from this study suggest that duration of a maximal sprint 
exercise bout or perhaps, more specifically, the amount of muscle mass used and work 
produced has an effect on both the amplitude and duration of the GH response (Stokes, 
2002a). 
 Stokes and colleagues (2002b) also examined the GH response to maximal sprint 
cycling at different pedaling rates.  The authors were interested in seeing if the GH 
response was different for varied pedaling rates and if repeated bouts of sprint exercise 
attenuated the GH response. The authors cited studies that showed simliar metabolic 
responses following maximal cycling at fast and slow pedaling rates [140 and 60 rpm 
respectively](Jones, McCartney et al. 1985). Therefore Stokes and colleagues believed 
that if metabolic responses determined the exercise induced GH response, the two 
conditions would yield similar results.  Subjects in this study completed two 30s maximal 
sprints separated by 60 min of recovery.   Resistance for the subjects was set at either 
7.5% (fast) or 10% (slow) of their body weight to elicit different pedaling rates.  Between 
the two trials there was no difference in peak or mean power output, but peak power 
output was slightly lower in the second sprint regardless of resistance (fast or slow).  
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Peak GH response after the initial fast sprint was more than twice as great as that after the 
initial slow sprint (37.7 ± 6.0 vs. 17.6 ± 3.7 mU/l respectively; P < 0.05) and mean GH 
area under the curve (AUC) during 60 minutes of recovery from sprint 1 was also 
elevated in the fast vs. slow trial (1,697 ± 367 vs. 933 ± 306 min·mU
-1
·l
-1
 respectively; P 
= 0.06).  There was no increase in serum GH concentration after the second sprint in 
either trial although the rate of GH clearance did slow after the second sprint.  The exact 
mechanism for the increase in serum GH concentration due to faster pedaling rates is not 
known, but was suggested to be related to muscle mass recruited (Stokes, Nevill et al. 
2002).  Additionally the increased GH concentration could be the result of increased 
frequency of neural firing during the fast trial as there was significant correlation between 
mean pedal revolutions and GH AUC (r = 0.59, P < 0.01 for sprint 1) as well as peak 
pedal revolutions (r = 0.48, P < 0.05 in sprint 1).  These findings contradict those of 
Kanaley et. al. (1997), that reported subesequent 30 min aerobic exercise bouts following 
a similar 60 minute passive recovery period, to produce distinct GH pulses.  However, 
the aerobic exercise study reported much lower GH AUC after exercise than that 
observed in the sprinting study (Kanaley, Weltman et al. 1997; Stokes, Nevill et al. 
2002). 
 Stokes and colleagues (2005) further investigated the attenuation of the GH 
response after a second bout of sprint exercise.  Subjects completed a 30s sprint on a 
cycle ergometer followed by either 60 or 240 minutes of passive recovery before 
attempting another 30s maximal sprint.  Results indicated that the GH response did not 
increase after the second sprint after the 60 minute recovery trial.  During the 240 minute 
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trial, GH concentration was back to baseline by 120 minutes and the second sprint 
produced a second increase in serum GH concentration that was smaller in magnitude 
than the initial response.  The authors infered that the amount of recovery time influenced 
the amount of GH released, but similar GH outputs were seen the next day.  This suggests 
that a short term negative feedback loop exists in the hypothalamic-pituitary axis and 
plays a role in the control of GH release.  It appears that in some circumstances, the 
negative feedback loop can override the exercise stimulus for GH release. (Stokes, Nevill 
et al. 2005). In contrast, several studies have reported the discrete ability of exercise to 
breakthrough this negative feedback loop (Kanaley et al 1997, Veldhuis et al 2004), but 
these studies used constant load aerobic exercise as the stimulus.  
 Stokes and colleagues (2003), examined the reproducibility of the GH response to 
a 30s maximal sprint on a cycle ergometer.  Subjects performed two trials of a single 30s 
cycle ergometer sprint separated by 7 days.  The authors found no significant difference 
in mean power output between the two sprint trials (725 ± 84 vs. 721 ± 84 W, P = 0.81), 
even though some subjects had an increase in peak GH output during the second sprint 
there was no significant difference in mean GH concentration between trials.  There was 
a large interindividual variability in the GH output between subjects but this is decidedly 
normal (Gordon et al 1994, Wideman et al 2002).  However, the authors in this study 
were more interested in the intra-individual variability in GH output with respect to sprint 
exercise.  Area under the curve (AUC) was not found to be statistically different between 
trials and the test-retest correlation was found to be statistically significant (r = .97).  This 
study supports previous work that there is a large interindividual variability in the GH 
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response to acute exercise (Raynaud, Capderou et al. 1983; Wideman, Weltman et al. 
1999; Stokes, Nevill et al. 2002), but was the first to show it with sprint exercise.  This 
study shows that despite the interindividual variation in the exercise-induced GH 
response, the intraindividual GH response to sprint exercise on a cycle ergometer was 
highly reproducible (Stokes, Nevill et al. 2003). 
 Gordon and colleagues (1994) examined the effect of acid-base balance on the 
serum concentration of GH in the blood after acute high-intensity cycling exercise.  
Subjects were either given a placebo or a solution of NaHCO3 and were asked to perform 
a maximal sprint exercise bout of 90 seconds at 0.49 N (0.05kg)/kg body weight.  As a 
result of NaHCO3 solution ingestion, blood pH was lower in the placebo group at all 
points except baseline and serum GH concentrations were higher in the placebo group at 
15, 20, and 30 minutes post-exercise.  The authors believed that although it is not the 
only factor, [H
+
] may have an effect on the release of GH after acute exercise (Gordon, 
Kraemer et al. 1994).  
 Thus, acute sprint exercise has been shown by multiple studies to be a valid and 
predictable stimulus for growth hormone release in men.  It seems to have a larger 
amplitude than submaximal aerobic exercise, which most likely results in the attenuation 
of GH release when multiple bouts of sprint exercise are employed.  However, few 
studies have examined the long term effects of sprint training on the GH response to 
sprint exercise. 
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Sprint Training 
 Stokes and colleagues (2004) were the first to examine the acute GH response to 
sprint cycling after sprint training.  Subjects completed two 30s maximal sprints on a 
cycle ergometer against a load equivalent to 7.5% of their body mass separated by 60 
minutes of rest.  The training involved three supervised training sessions per week that 
were either speed or speed-endurance training.  During speed sessions the participants 
sprinted against a resistance of 4% body mass to develop speed while during speed-
endurance sessions subjects pedaled against a resistance of 11% body mass in an attempt 
to develop lean muscle mass and strength.  After 6 weeks of training there was a decrease 
in the peak GH response to sprint exercise (10.3 ± 3.1 vs 5.8 ± 2.5 μg/l, P < 0.05).  This 
study reported that a 6 week sprint training program can decrease the GH response to 
sprint exercise with between 3 and 5 days rest between training a testing  
sessions (Stokes, Nevill et al. 2004). 
 Burgomaster and colleagues (2005) examined the effects of sprint training on 
muscle oxidative potential, VO2peak, and time to fatigue while cycling at an intensity 
equivalent to 80% of VO2peak.  The authors utilized a two week training protocol with 1-2 
days of rest in between sprint training sessions.  Training protocols consisted of 4-6 
maximal 30s sprints with a resistance of 7.5% body weight.  After training, cycle 
endurance capacity increased significantly as well as anaerobic work capacity and muscle 
oxidative capacity.  This study demonstrates that sprint cycle training was effective in 
improving sprint as well as endurance performance (Burgomaster, Hughes et al. 2005). 
 
 
15 
 
Table 3. Summary of response to sprint cycle training 
 
Study  Subjects Exercise  Chronic Training Effects  
Stokes (2004)  8 Males 
Recreationally 
active  
age = 24 (1.1) 
Examined acute GH 
response to sprint cycling 
before and after 6 weeks 
of training 
Two 30s sprints separated 
by 60 min rest 
30s training sessions 
pedaling against either 
4% or 11% body mass  
There was a decrease in peak GH 
response to sprint exercise  (10.3 
± 3.1 vs 5.8 ± 2.5 μg/l)* 
 
AUC (µg/l) 567 (158) vs 256 
(121)* 
 
PP (W) 1395 (83) vs 1470 (73) 
PP-corr (W) 18.0 (0.8) vs 19.2 
(0.6) 
MP (W) 656 (40) vs 692 (29) 
MP-corr (W) 8.5 (0.3) vs 9.0 (0.1) 
Burgomaster 
(2008)  
10 males and 
10 females 
untrained 
<2x/wk (5 of 
each per 
group) 
30s  at 7.5% body weight 
4-6x 3 day/wk for 2 
weeks.   
Post-training cycle endurance 
capacity  as well as anaerobic 
capacity increased significantly  
 
  
Stokes et al. (2004) have shown a clearly defined response of GH to six weeks of 
sprint training, but it is the only study investigating the effects of sprint training on GH 
release and no midpoint training measures were taken so the time course of changes is 
not known.  Studies have also shown that sprint training can influence both endurance 
capacity and power output through skeletal muscle adaptation (Burgomaster, Hughes et 
al. 2005; Gibala, Little et al. 2006).  However, there is still no information as to the time 
course of the training adaptation within these studies.  Thus, the proposed study will 
investigate the GH time course adaptation within the first 3-weeks of a sprint training 
protocol. 
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CHAPTER III 
METHODS 
 
 
Subjects 
 
 Eight recreationally active males (age = 26.8 ± 4.3 years) completed this study 
and baseline characteristics of the subjects are presented in Table 4. Subjects participated 
in less than 10 hours of recreational (swimming, basketball, jogging, cycling etc.) activity 
per week and were not involved in any sprint (interval) training.  Subjects had a BMI 
between 18 and 30 and were non-smokers [had not smoked within the previous 6 
months].  Subjects gave written informed consent to participate in this study as approved 
by the Institutional Review Board committee of the University of North Carolina at 
Greensboro.  For safety reasons subjects with two or more risk factors for cardiovascular 
disease as defined by the American College 
of Sports Medicine were excluded from 
participation in this study. 
Baseline and Post-Study Measurements 
 
 Individuals who met the inclusion 
criteria attended a preliminary screening & 
data collection session. Subjects will gave 
written informed consent (See appendix) to 
Table 4.  Baseline subject 
characteristics 
 
Subj. Characteristic mean (SD) 
Age 26.8 (4.3) 
 
Height 177 (5.0) cm  
 
Weight 77.8 (7.35) 
 
VO2max 47.03 (7.26) 
 
% body fat 
 
17.72 ( 4.76) 
 
BMI 24.7 (1.74) 
17 
 
participate in this study as approved by the Institutional Review Board at the University 
of North Carolina at Greensboro. Height was recorded to the nearest centimeter using a 
stadiometer and weight was recorded to the nearest 0.1 kg using an electronically 
calibrated scale (Seca, Vogel and Halke; Hamburg, Germany). 
 Subjects filled out a detailed medical history form and a physical activity history 
form (see appendix). Subjects with two or more risk factors for cardiovascular disease as 
defined by the American College of Sports Medicine were excluded from participation in 
this study. Subjects completed a brief familiarization session on the cycle ergometer 
(Lode Excalibur Sport.  Lode BV, Groningen, The Netherlands), so they can experience 
cycling on electronically braked equipment and get bike set up position. This entire 
preliminary session took no more than 30 minutes. 
Total and regional body composition were assessed using a whole body dual 
energy X-ray absorptiometry scan (DXA) [Lunar –Prodigy Advance Plus] at either the 
preliminary data collection session or at the baseline measurement session dependent on 
the availability of the DXA schedule. Subjects were asked to wear loose fitting clothing 
and to remove glasses and all jewelry.  Subjects were asked to lay still and flat on the x-
ray table, while scans were performed in fan beam mode (scan time ~10-20 min).  Bone 
area (BA), bone mineral density (BMD), bone mineral content (BMC), fat mass (FM) and 
fat-free mass (FFM) were measured for the whole body and regional areas. All scans 
and analysis were completed by a trained DXA technician.  
Subjects completed a standardized VO2peak protocol on the electronically braked 
cycle ergometer. Briefly, subjects were asked to do a warm-up on the bike for 2 minutes 
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at 25-50 Watts. VO2peak protocol consists of beginning the initial three 2-minute stages at 
50, 100, and 150 W respectively. After this, the work was increased 50 W every minute 
until volitional fatigue. VO2peak corresponded to the highest value achieved during any 
30s collection period.  Subjects then completed an active recovery at 50 Watts for 2 
minutes. Oxygen consumption and carbon dioxide production were measured using open 
circuit spirometry (TrueOne 2400 Metabolic Measurement System. ParvoMedics, Inc. 
Sandy, Utah) calibrated to known gases and a Polar heart rate monitor was used to assess 
heart rate during the entire protocol. The entire testing process took 20-30 minutes 
depending on the subject’s fitness level.    
Baseline Resting Blood Sampling 
 
 Prior to initiating the training protocol, subjects entered the exercise physiology 
lab after an overnight fast (8-12 hrs) to complete a baseline 2 hour blood profile.  A 
catheter was inserted into an arm vein by a trained technician and blood was taken every 
15 minutes for 2 hrs, with more frequent sampling near the time that exercise would 
occur during the exercise-stimulated trials.  Patency was maintained by displacing the 
blood in the catheter with isotonic saline.  Blood samples were taken with the subject in a 
seated position at 0, 15, 30, 31 (time of exercise), 35, 45, 60, 75, 90, 105, and 120, 
minutes.  Blood samples were collected in red-top vacutainers (10 ml) and a total of 110 
ml or 110 cc of blood was collected over the 2 hr time frame. Blood samples were 
analyzed by GH ELIZA 07BC1033 (MP Biomedicals, Solon, Ohio).  After completion of 
the resting hormonal profile, participants were scheduled for their baseline exercise 
profiles.  
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Sprint Test Protocol 
 
  Subjects were asked to return to the exercise physiology lab at least 48 hrs after 
the baseline measurements have been completed (but no longer than 2 weeks). A catheter 
was inserted into an arm vein by a trained technician and blood was taken as outlined in 
the previous section. After 20 minutes, subjects began a standardized submaximal warm-
up.  Warm-up consisted of pedaling at 60 watts (W) for 4 min, pedaling at 80 W for 30s, 
and pedaling at 100 W for another 30s.  Subjects were then told to rest for 5 minutes 
before the 30s maximal sprint. During the sprint test subjects completed one maximal 30s 
sprint against a load equivalent to 7.5% of their body mass.  Subjects were instructed to 
begin pedaling at maximal pedal speed for 2-3 seconds at which point the resistance was 
applied.  Heart rate was assessed throughout exercise using a Polar heart rate monitor and 
heart rate was recorded every 5 seconds during exercise. Immediately after the test, a 
post-exercise blood sample was taken while the subject remained seated on the 
ergometer. After the immediate post-exercise sample was taken, the subject moved into a 
chair to rest comfortably for the remaining blood draws. Subjects were instructed to give 
maximal effort during each of the test trials and verbal encouragement was provided by 
the research team. Total work completed, peak and average power output were calculated 
from the Wingate test.  
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Figure 1.  Timeline of acute sprint  
Training 
 
 At least 36 hours after completion of all baseline testing sessions, subjects began 
the 3-week training protocol.  Training protocol is based upon the 2-week training 
protocol developed by Burgomaster and colleagues (2005).  Training consisted of 3 
sessions per week with one rest day in between sessions.  The first 3 training sessions 
consisted of four 30s repetitions at 7.5% body mass with 4 minutes of active recovery at 
50 W between each repetition.  Training sessions 4-6 [week 2] consisted of 5 repetitions, 
and sessions 7-9 [week 3] consisted of six 30s maximal repetitions.  During each 
repetition subjects were encouraged verbally to provide maximal effort. At the end of 
each week, 2 days after the third training session for the week, subjects completed the 
sprint test protocol outlined previously (including blood draws). At least 24 hrs after the 
final blood profile, a post-training VO2max test was completed as outlined previously.   
 
 
21 
 
Table 5. Timeline of subject visits to laboratory 
Sunday  Monday  Tuesday  Wednesday  Thursday  Friday  Saturday  
  DXA 
VO2max 
 2 hr resting 
profile 
  
Test Sprint #1  4 x 30s   4 x 30s   4 x 30s  
Test Sprint #2  5 x 30s   5 x 30s   5 x 30s   
Test Sprint #3  6 x 30s   6 x 30s   6 x 30s   
Test Sprint #4  DXA 
VO2max 
    
 
 
Statistical Analysis 
 
 Descriptive data (mean ± SEM) was calculated for subject characteristics such as 
HR, power, height, weight, and age.  
Total area under the curve (AUC) for GH was calculated using trapezoidal 
integration. Mean GH concentration, peak GH concentration attained and AUC were 
assessed to determine the serum GH response to sprint exercise.  Training was expected 
to result in increased work during each of the weekly sprint trials.  Therefore, total GH 
area under the curve was normalized for work completed during the sprint trial (GH 
response = AUC/W).   The effect of training on all dependent variables was assessed 
using a one-way ANOVA with repeated measures.  Independence of observations and 
normality were tested and when these assumptions were met, sphericity was assumed and 
no correction factor was used. When assumptions were violated, corrections were utilized 
as indicated in the Results. 
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GH Assay 
 This protocol utilized an HGH ELISA from MP Biomedicals (Solon, OH).  
Specimens were frozen at -80 C until being prepared for assay.  Serum was then thawed 
for 1 hr prior to assay procedure.  Due to use of manual pipetting only 32 wells were 
utilized for each assay run to keep pipetting time to under 3 minutes as recommended by 
assay insert.  All samples were run in duplicate.  Absorbance was run at 450 nm in a 
microtiter plate reader.  Specimens were compared to dublicate values and reference 
standards to determine sample concentration.  Assay was sensitive to a detectible 
concentration of 0.5 ng/mL. 
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CHAPTER IV 
 
RESULTS 
 
 
Maximal Oxygen Consumption 
 VO2max testing was completed pre and post training to determine the effects of 
sprint training on maximal aerobic capacity. Neither absolute nor relative VO2max was 
increased as a result of 3 weeks of sprint training (3.68 ± 0.77 L/min vs. 3.73 ± 0.82 
L/min, P = 0.53, and 47.03 ± 7.26 ml/kg/min vs. 47.46 ± 7.98 ml/kg/min, P = 0.66, 
respectively).  Maximum heart rate (184.63 ± 8.11 vs. 184 ± 6.52, P = 0.72) and RPE 
(17.88 ± 1.64 vs. 18.25 ± 1.04, P = 0.5), did not differ significantly from pre to post 
training. However, the maximum workload attained during the VO2max test did increase 
significantly from pre to post-training (318.75 ± 59.39 vs. 343.75 ± 62.32, P = 0.033).   
Body Composition 
During the 3 week sprint training period, fat mass decreased (17.73 ± 4.76 vs. 
16.81 ± 4.93, P = .036), while LBM increased (62.05 ± 7.13 vs. 62.90 ± 6.85, P = 0.049), 
with no significant changes in total body mass; (78.79 ± 7.35 vs. 78.13 ± 7.42, P = 
0.402). Thigh girth was also unchanged in response to training (54.34 ± 3.41 vs. 54.19 ± 
3.21, P = 0.86). 
Training Related Changes 
 Within subject differences in mean total work output during training was assessed 
with a repeated measures ANOVA (Table 6), and the results indicate that there were no 
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significant difference between the mean total work output for each week [F (2, 14) = 
1.278, p = 0.309].  However, a linear trend for decreased mean work completed across 
the 3 weeks of training did approach significance (p = .07) 
 
 
 
Mean peak power during each week of training was also assessed (Table 7).  In 
this case, the assumption of sphericity was violated and a Huynh-Feldt correction was 
used.  There were no differences in the mean peak power output across the 3 weeks of 
training  [F (1.8, 12.8) = 2.498, p = .12].   
 
Table 7.   Mean and standard deviation for peak power during each week of training 
 
  Mean Std. Deviation 
Week 1 1021.48 177.31 
Week 2 1047.87 177.68 
Week 3 1053.99 186.73 
   
 
Likewise, the weekly average of the mean power output for each training week 
was not different across the three weeks of training [F (2, 14) = .836, p = .45] (Table 8).     
 
 
Table 6. Total and mean of total work (KJ) by week.  The total work for each 
individual sprint during the training week was averaged to attain the weekly mean. 
 
  Mean Std. Deviation Weekly Total Work Std. Deviation 
Week 1 15.10 3.015 179.63 34.135 
Week 2 15.01 3.089 225.23 46.330 
Week 3 14.84 2.747 267.43 48.794 
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Analyzing only the data from the sprint with the highest peak power from each 
training session to remove the effect of added sprints yielded similar results. The mean 
peak and mean power did not change across the three weeks of training [F(1.2, 8.3) = 
2.355, p = .16 and F(2, 14) = 0.984, p = .398, respectively] (Table 9). 
 
Table 9. Mean and peak power average for training week using only the sprint with 
highest peak power for each training day.  Means are presented as Means (SD).  n = 8. 
 
 Mean Power Peak Power 
Week 1 585.00 (104.80) 1166.63 (172.57) 
Week 2 605.75 (113.90) 1166.96 (192.60) 
Week 3 578.54 (117.31) 1199.46 (174.41) 
 
 
Acute Sprint Trials 
Differences in the mean power attained during each acute sprint trial were 
assessed by repeated measures ANOVA.  The assumption of sphericity was violated, 
thus, a Huynh-Feldt correction was used.  Mean power was unchanged across the acute 
sprint trials [F (2.7, 19.1) = .669, p = 0.568] (Table 10).   
 
 
Table 8. Weekly average of the mean power output for each training bout for the 3-weeks 
of training. 
 
  Mean Std. Deviation 
Week 1 501.58 98.13 
Week 2 500.44 102.97 
Week 3 494.89 90.23 
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Significant differences in peak power across each acute sprint trial were observed 
[F (2.6, 18.3) = 4.385, p < .05] (Table 11).  A Huynh-Feldt correction factor was used, 
since the assumption of sphericity was violated. Post-hoc comparisons revealed that peak 
power increased significantly as a result of training in acute sprint trial 1 compared to 
acute sprint trial 4 (1160.63 ± 135.39 vs. 1247.25 ± 140.04, P < .05).  Given the 
significant correlation of lean body mass on peak power (Pre; r= .826, p = .011, Post; r = 
.876, p = .004), the results were adjusted to correct for LBM.  A paired samples t-test was 
performed and showed that a significant difference was observed even when peak power 
was corrected for lean body mass (p < 0.05, Table 11). 
 
Table 11.  Average peak power and peak power corrected for by lean body mass and 
standard deviations across all acute sprint trials. N=8 
 
  Mean(SD) Mean-corr (SD) in W/kg LBM 
AS1 1160.63 (135.39) 8.51 (0.55) 
AS2 1212.88 (149.99) 
 
AS3 1180.88(167.70) 
 
AS4 1247.25(140.04) 9.03 (0.49) 
 
 
When analyzed by repeated measures ANOVA time to peak power (TTP) was not 
significantly different across the four acute sprint trials, although the P value trended 
Table 10.  Mean power and standard deviation during each acute sprint (N=8). 
 
  Mean Std. Deviation 
Mean Power AS1 603.13 119.50 
Mean Power AS2 602.13 114.66 
Mean Power AS3 608.38 105.60 
Mean Power AS4 586.13 109.19 
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toward a significantly shorter TTP after training[F (1.2, 8.4) = 3.42, p = 0.096] (Table 
12).  
 
Table 12.  Mean TTP and standard deviation across all acute sprint trials (s). 
 
  Mean Std. Deviation 
TTP AS1 1.725 1.377 
TTP AS2 0.825 0.328 
TTP AS3 0.775 0.311 
TTP AS4 0.725 0.385 
 
 
Analysis of the total work completed (KJ) during each acute sprint trial, revealed 
that there were no significant differences [F(2.7, 13.8) = .67, p = .568] (Table 13).   
 
Table 13.  Total work in KJ and standard deviation of each acute sprint trial (N=8) 
 
  Mean Std. Deviation 
AS1 18.09 3.58 
AS2 18.06 3.44 
AS3 18.25 3.17 
AS4 17.58 3.28 
 
When analyzed by repeated measures ANOVA maximum heart rate across all 
acute sprint trials tended to decrease, but the changes were not significant [Wilks Lambda 
= 0.552, F = 1.355, p = 0.357].  
The average GH profile for the resting baseline trial and for each acute sprint trial 
is depicted in Figure 1. The GH AUC for each of the four acute sprint tests and the 
resting baseline was assessed using repeated measures ANOVA.  The assumption of 
sphericity was violated in all analyses related to GH AUC and a Greenhouse-Geisser 
correction was used for all these analyses.  Despite that the GH AUC for AS1 was greater 
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than the other 3 trials, the results indicate that the GH AUC did not differ significantly for 
any of the trials [F (1.5, 10.8) = 3.452, p = 0.078, eta
2
 = .55] (Table 14). 
 
Table 14.  Mean and standard error of the GH AUC and correction factors for the five 2 hour 
profiles. All values are mean (SEM) 
 
 GH AUC  GH AUC per LBM GH AUC per KJ GH Peak Time to GH Peak 
Rest 166.02 (61.39) 2.57 (.90)  3.36 (1.51) 42.63 (12.12) 
AS 1 530.13 (185.77) 8.45 (3.00) 28.93 (10.39) 8.42 (2.95) 54.38 (7.99) 
AS 2 226.15 (81.85) 3.59 (1.21) 12.65 (4.14) 4.25 (1.68) 41.88 (6.68) 
AS 3 213.86 (110.47) 3.28 (1.59) 11.12 (5.26) 2.94 (1.25) 38.13 (9.35) 
AS 4 205.83 (97.26) 3.18 (1.41) 10.46 (4.95) 4.12 (1.78) 48.88 (5.43) 
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Figure 2.  Mean (±SEM) profile of GH output in response to each of the 4 acute sprint 
trials.  
 
Because GH AUC is influenced by LBM and total work completed we 
normalized GH release based on these factors.  Normalizing GH AUC for LBM [F 
(1.461, 10.226) = 3.453, p = 0.082, eta
2
 = .33] did not alter the initial findings related to 
GH AUC. Normalizing GH AUC for total work completed (KJ) approached, but did not 
reach, significance [F (1.12, 7.84) = 4.194, p = 0.073, eta
2
 = .38].   
Peak GH showed a trend toward a decrease across the four acute sprint trials.  
Sphericity was violated and a Greenhouse-Geisser correction was used (F = 4.439, p = 
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0.059, eta
2
 = 0.39).  Time to peak (GH TTP) did not differ significantly across sprint 
trials (F = 2.513, p = .173) 
 
0
100
200
300
400
500
600
700
800
AS1 AS2 AS3 AS4
G
H
 A
U
C
 (
µ
g/
l/
m
in
)
Visit
 
 
Figure 3. Mean 2 hour GH AUC for each of the five acute sprint profiles. 
 
  
The change between peak GH and pre-exercise levels significantly differed across 
the four acute sprint trials (F = 5.115, p = .040, eta
2
 = .422).
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CHAPTER V 
 
DISCUSSION 
 
 
 The present study showed that three weeks of sprint exercise training can; 1) 
increase peak power output during a 30 second wingate test, 2) decrease percent body fat 
and 3) increase lean body mass.  
 Prior to any sprint training, GH AUC in response to an acute sprint has been 
reported to be 270.9 ± 296.7 (Stokes et al. , 2003) and 567 ± 158 min·µg·l
-1
 (Stokes et al, 
2004), compared to  530.13 ± 525.45 prior to training in our study. It should be noted that 
the recovery period after the 30-second sprint was 60 minutes in the previous two studies, 
while it was 90 minutes in our study.  Weltman et al. (1977), showed that GH adaptation 
to acute constant load cycling had already occurred after 3 weeks of training and was 
similar when re-assessed after 6-weeks of training (pre- 238 ± 145 min·µg·l
-1
; wk 3- 138 
± 106 min·µg·l
-1
; wk 6- 130 ± 145 min·µg·l
-1
).  However, the intensity of the training 
sessions and acute sprint tests remained at the same absolute level and thus, did not 
represent the same relative intensity as prior to training.   It is important to note that the 
current sprint training study required maximal effort for each acute trial and therefore 
represented a consistent relative intensity of 100%.  In addition, the work load was 
adjusted for even minor changes in body weight to minimize changes in relative intensity.  
Thus the intent of our study was specifically to address the time course of adaptation in 
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GH output in response to sprint training in the first 3 weeks of the training cycle. 
While the GH response to sprint exercise has been well documented (Stokes, Nevill et al. 
2002; Stokes, Nevill et al. 2002; Stokes, Nevill et al. 2003; Stokes, Nevill et al. 2004; 
Stokes, Nevill et al. 2005) and has been reported to be reproducible (Stokes 2003) the 
current study is the only one to track the week to week time course of adaptation in GH 
output in response to sprint training.  Stokes and colleagues (Stokes, Nevill et al. 2004) 
investigated the GH responses to 3 and 6 weeks of sprint training, without investigating 
the weekly changes in GH output with training.  Similar to previous reports utilizing 
acute sprint exercise, we observed an increase in GH output (Figure 1), after as little as 
30 seconds of sprinting (Stokes, Nevill et al. 2003; Stokes, Nevill et al. 2005), but the 
interindividual variability in the GH response was still large. Peak GH in previous sprint 
studies ranged between 10.7 ± 11.1 and 15.0 ± 14.8 µg·l
-1
, compared to a peak GH of 
8.42 ± 8.34 µg·l
-1
 in our study (means ± SD). With training, the peak GH values in our 
study tended to decrease about 4 µg·l
-1
 (8.42 ± 8.34 vs 4.12 ± 5.05 µg·l
-1
), which is 
consistent with the decreases in peak GH observed by Stokes et al (2003), who reported a 
decrease of about 4.5 µg·l
-1 
(10.3 ± 3.3 vs 5.8 ± 2.5 µg·l
-1
) after 6 weeks of training. This 
corresponds to a mean decrease in peak GH concentration of 50% in response to 3 weeks 
of sprint training, compared to about a 40% decrease in peak GH concentration in the 
Stokes study after 6 weeks of training.  
The present study saw a 61% decrease in mean GH AUC from AS1 to AS4 
compared to a 55% (P < 0.05) decrease in mean GH AUC in the Stokes study.  The value 
in the present study was not significant, possibly due to the large interindividual 
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variability between subjects or the small (n = 8) sample size, but is similar to what has 
been reported previously with sprint training. Even with these minor differences it 
appears that after 3 and 6 weeks of sprint training exercise-induced GH outputs are lower 
and remain relatively similar during the 3 to 6 week timeframe.  Therefore it appears that 
adaptation in GH output begins to occur in the initial 3 weeks of training. 
GH peak results in this study are comparable to those found in acute resistance 
exercise studies which found peak GH levels of 5-25 µg·l
-1
 with levels returning to 
baseline values around 90 minutes post-exercise (Wideman, Weltman et al. 2002).  This 
also agrees with a study by Kraemer et al. (1998),  using a heavy resistance exercise 
protocol that consisted of 4 sets of a 10 repetition maximum squat exercise and elicited a 
peak GH response of about 8.5 µg · l
-1
 at 30 minutes post exercise (Kraemer, Hakkinen et 
al. 1998).  This study utilized a large muscle mass exercise (squats) that is similar to the 
muscle mass activated in the present study when completing all out maximal sprint 
exercise on a cycle ergometer.  The Kraemer study also noted that while GH levels were 
elevated at cessation of exercise, they were not significantly different from baseline. This 
finding is similar to what we noted in the current study with sprint exercise, but is 
completely different than the GH profiles noted with endurance exercise.  This difference 
may be due to the short duration of the actual exercise performed in these aforementioned 
resistance and sprint exercise protocols, compared to endurance exercise protocols. Even 
though the endurance exercise was only 10 minutes, it was still 20 fold longer than the 
sprint exercise (10 min/0.5 min) and while the total amount of time for the resistance 
exercise was actually longer than the endurance exercise utilized in the Weltman 
34 
 
investigation, resistance exercise is intermittent and this may have altered the peak GH 
response.  In the Weltman (2008) study the GH response occurs near or immediately after 
the termination of exercise in a 10 minute endurance exercise bout.  It appears that this 
delay from the onset of exercise is similar to the delay in peak GH concentrations seen in 
our study.  The 24-hour AUC does not differ in the Weltman study between the 3x10 min 
and 30 min continuous bouts which were both at the same intensity.It appears that 
significant elevations in GH concentrations past the immediate post exercise measure are 
not as likely in short duration protocols.  The longer duration protocols may produce 
more elevations in GH due to the increased amount of work performed over the exercise 
period.  This may explain why shorter duration protocols do not see a GH response that is 
as elevated as those of longer duration. 
One notable finding is the change in difference from pre-exercise and peak GH 
levels across the acute sprint trials while total work remained the same.  There could be 
several factors related to this occurrence most likely an adaptation to the activity or more 
sensitivity to circulating GH.  This does note a significant change in the level of GH 
released in response to an acute sprint trial while also taking into account GH levels pre-
exercise. 
 Another notable and somewhat surprising finding from the current investigation 
was that lean body mass increased with a concomitant decrease in fat mass and no change 
in total body mass after only 3 weeks of sprint training.  Exercise induced GH release 
leads to protein sparing and increased lipolysis which could facilitate the maintenance of 
lean mass and decreases in fat mass (Frisch 1999). Increases in lean body mass also assist 
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in maintaining resting metabolic rate which may lead to decreases in body fat (McMurray 
and Hackney 2005).  The high  intensity and longer total duration of the training bouts [> 
30 minutes in total duration and ~ 3 minutes of cumulative all out maximal exercise], 
would have elicited a marked GH response that was likely greater than that of the acute 
sprint tests.  The anaerobic nature of these short training bouts most likely led to an 
accumulation of catecholamines in the blood and recruitment of primarily Type II motor 
units which as stated in Consitt (2007) is purported to stimulate an increase in GH 
release. In addition Kanaley (2004) noted GH release increased the release and turnover 
of free fatty acids post-exercise in men and GH deficient men who were administered GH 
pre-exercise.  Pritzlaff (2000) also found that the increased usage of fat as a fuel source 
during recovery was positively correlated with increase in exercise intensity.   
Although the changes in body composition were small they were still significant 
even with a small sample size.  Five of 8 subjects decreased total fat mass and increased 
total lean mass, without significant changes in total body mass.  Of note is the usage of a 
DXA scanner in measurement of body composition in the current study.  The DXA is the 
gold standard in measurement of bone mineral density but there may be issues in the 
efficacy of soft tissue analysis.  For confirmation of the results found in this study it is 
suggested that a similar study with a larger sample size be performed to compare results. 
The intense nature of the training utilized in this study brings to the forefront the 
concept of overtraining as a mediator of the results.  Although assessing overtraining 
markers is beyond the scope of the current study, some of the subjects made comments 
about their fatigue levels which lead the authors to believe they may have been 
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experiencing overtraining syndrome.  Future studies should look into the concept that 
stress hormones may have played a role in the body composition changes found in this 
study.    In a study of overtrained runners, Barron et al. (1985) noted decreases in the GH 
response to insulin hypoglycemia.  Urhausen et al. (1998) studied endurance athletes for 
1.5 years and found a decrease in exercise-induced GH release in response to an 
endurance test at 110% of the subjects’ anaerobic threshold.  Blood was taken 
immediately post as well as 5 and 10 minutes post-exercise.  In our study the immediate 
and 5 minute post values did not significantly differ across all acute sprint trials.  The 15 
minute post-exercise value trended toward significance (Greenhouse-Geisser; F = 3.67, P 
= 0.083) across all trials.  It is possible these subjects were experiencing overtraining 
syndrome but analysis of other markers of overtraining syndrome must be addressed to 
make this conclusion. 
VO2max did not increase after 3 weeks of sprint training in the current study, and 
these findings are consistent with those reported in other sprint training protocols of 
similar  length  (Burgomaster, GJF et al. 2006). The present study also noted similar 
effects with respect to heart rate changes during the VO2max test.  One notable finding in 
the present study is an increase in workload attained at the same VO2max.  These results 
suggest that short term sprint training can increase muscle oxidative capacity even in a 
short time period.  This may be a result of reduced lactate accumulation and reduced 
glycogenolysis like that noted in matched-work exercise after two-weeks of sprint 
training in the study by Burgomaster, et al ((Burgomaster, Hughes et al. 2005).  In 
addition Burgomaster et al. (2006) found an increase in citrate synthase activity and 
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stored muscle glycogen posttraining (Burgomaster, GJF et al. 2006).  It is believed by the 
authors that a notable increase in VO2max would require a longer training program such 
as the study by Weltman et al (1997) which found increased VO2max (3.15 ± 0.54 vs. 
3.41 ± 0.47 L/min; P < 0.05) and increased power output values at VO2max (223 ± 40 vs. 
263 ± 31 W; P < 0.05) after 6 weeks of endurance training on a cycle ergometer.  While 
small changes in oxidative capacity may occur in as little as 2 weeks, it is well 
documented  that changes in tissue related to oxygen delivery, such as increased capillary 
density, take longer to occur (McArdle, 2007).  
 The concept of interval or high intensity training has been widely studied for the 
use of performance enhancement for the athletic population.  The author believes that 
high intensity training could be a viable alternative to endurance style aerobic training in 
the normal and special populations as well.  The heavy workload of this particular 
protocol would prove difficult for most populations.  However, adjustments to training 
intensity via alterations in resistance, duration, repetitions, and sessions per week could 
allow for more manageable and effective training for other populations.  Interval training 
can provide a more time effective means of exercise for individuals who cannot devote 
30-60 minutes to moderate intensity exercise.  Additionally as has been shown in the 
present study, it appears that this type of interval training can improve lean body mass 
and decrease fat stores which could lead to improved maintenance of body composition 
in addition to cardiovascular benefits.  
 The lack of substantial findings for GH variables was likely due to a combination 
of the large inter-individual variability in GH output and the small sample size of the 
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current study.  Therefore future studies should include a larger sample size in order to 
minimize the effects of the large inter-individual variability in GH release.  Possible 
further research should include the effects of this type of training on those of aging 
individuals as well as the sedentary population.  High-intensity sprint training if practiced 
correctly could be a viable alternative to traditional endurance training for the normal 
population with limited time for exercise. 
Possible limitations in the present study include that of subject motivation, 
homogenous population, and the possibility that the subjects were overtrained.  Subjects 
participated in high intensity exercise during 3 training sessions and 1 acute sprint session 
each week.  It is difficult to quantify the exertion level given by these subjects in each of 
these training bouts.  Subjects could have held back from maximal effort in order to 
conserve energy for subsequent sprints.  Although encouraged to perform maximally 
each time it is possible they may not have given maximal effort.  In this study we utilized 
a population of young active white males which limits generalization to other 
populations.  Future studies should address gender as well as age differences.  Yet 
another limitation to this study is the possibility that was discussed earlier that the 
subjects in this study may have been experiencing overtraining syndrome.  Overtraining 
syndrome can result in hormonal disruption as well as performance decrements.  One 
possible method to better tailor the training to the subjects’ fitness level to avoid 
overtraining may be to train subjects based off a percentage of peak power in a pre-
training cycle test.  
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In summary, we reject our hypothesis that a significant attenuation in peak growth 
hormone concentrations and growth hormone area under the curve would occur in 
response to an acute maximal 30-second sprint after sprint training.  We supported our 
hypothesis that VO2peak would not significantly increase in response to training.  We 
also supported our hypothesis that peak power during acute sprint trials would increase 
significantly in response to training.  Suggestions for future training protocols include 
training at an intensity level that is relative to LBM or VO2max instead of purely total 
body mass.  In conclusion, regular sprint exercise training may provide a viable 
alternative to longer durations of aerobic exercise for increasing GH output in some 
populations. However, the intensity of work required limits the use of sprint exercise in 
higher risk populations. Perhaps the best use of sprint exercise training is including it as a 
small part of a regular exercise program for individuals in the general population who are 
healthy. 
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APPENDIX A: 
 
 RECRUITMENT FLYER 
 
 
Male Research Participants Needed 
Male research participants are needed for a research study investigation the effect of sprint exercise training on 
hormones & oxidative stress markers 
You may be eligible for this study if you: You are not eligible for this study if you: 
 
 Are a male between the ages of 18 and 30 
 Currently exercise less than 5 hours per week 
 Are willing to exercise 3 times per week on the UNCG campus 
 Meet the study’s height/weight requirements  
 You currently exercise more than 5 hours per week 
 You currently train with sprint exercise 
 You currently smoke or quit smoking within the past 6 months 
 Have diabetes or heart disease 
This training study will last approximately 4 weeks and will include a free assessment of body fat percentage and a 3 
week supervised training plan in the UNCG Exercise Physiology Lab.  Exercise sessions will be three times per week (30 min each) 
and there will also be 1 testing session per week (2 hrs). 
 
For More information please contact:    
Jason K. Smith 
Department of Exercise & Sport Science 
University of North Carolina at Greensboro 
(704) 609-6367 
Jksmith3@spartan.uncg.edu 
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APPENDIX B:  
 
CONSENT FORM 
 
 
UNIVERSITY OF NORTH CAROLINA AT GREENSBORO 
CONSENT TO ACT AS A HUMAN PARTICIPANT 
 
Project Title: The hormonal & oxidative stress adaptation to short term sprint 
exercise training 
 
Primary Investigator:  Laurie Wideman, PhD 
Project Directors:  Jason K. Smith or Kevin Ritsche 
 
Participant's Name:  ____________________ 
 
Why are we doing this study? 
The purpose of this study is to compare how hormones [i.e. growth hormone] and oxidative stress 
markers change in response to acute exercise following short term (3 weeks) sprint exercise 
training. 
 
Who is eligible to participate? 
We are looking for individuals between the ages of 18 and 30, who are currently exercising 
between 3 and 5 hours per week.  You must be a non-smoker and not taking medications that are 
known to alter hormones. You cannot have any injuries to your lower body that would prevent you 
from participating in this study. 
 
What are we asking you to do? 
If you agree to participate in this study, these are the things that we will be asking you to do: 
 Come into the UNCG Exercise Physiology Laboratory to fill out a medical history 
questionnaire, have preliminary screening measurements and practice riding the stationary 
bicycle. This session will take ~ 30 minutes. 
 Go to the Stone Building to have a bone scan completed to assess how much body fat you 
have. This will take ~ 30 minutes, including transit time between buildings. 
 Perform a bike test that will get progressively harder to get your VO2max value (VO2max is the 
amount of oxygen your body uses to create energy). This will take ~20-30 minutes depending 
on how fit you are. 
 Return to the lab at least 24 hrs later and have a resting blood profile done, which will take 2 
hrs. The total blood taken will be just under half a cup [110 ml]. 
 At least 48 hrs later, return to the lab to have an exercise blood profile completed. This will 
require you to do a 30 second maximal sprint on the bike and we will collect blood samples 
before and after exercise. This will take ~2.5 hrs. 
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 Come in for 9 training sessions lasting about 30-45 minutes every other day for a total of 3 
weeks (3 sessions each week). 
 Come in for  additional exercise blood profiles after each week of training [i.e. after week 1, 2 
and 3 of training]. Each these sessions will take ~2.5 hrs.  
 Repeat the bike test for your VO2max on a separate day. 
The total amount of blood that will be taken during the course of the entire study is 550 ml [110 ml 
x 5 sessions] or just over half a quart [2 1/3 cups]. 
 
What are the possible risks and discomforts related to this study? 
There are minor risks that are possible as a result of participating in this study. These include 
muscle fatigue and dizziness during and after the exercise, abnormal changes in heart function, 
and, in very rare instances, heart attack (non-fatal or fatal) may also occur during the exercise test. 
However, the incidence of sudden cardiac death during vigorous exertion in healthy adults is 
extremely rare and is estimated at one death per year for every 15,000 to 18,000 individuals 
[ACSM 2006].  If you experience any pain during exercise you should immediately notify the 
researcher. In the unlikely event of an emergency, the researcher will provide Cardio-Pulmonary 
Resuscitation (CPR) and/or administer an Automatic External Defibrillator (AED) if appropriate and 
will call 911 for emergency assistance.  
Infection is possible when blood samples are taken, but the risk of infection will be minimized 
through the use of sterile techniques by a trained technician. Only slight discomfort should occur. 
You should feel slightly more pain than a mosquito bite when the catheter is placed. Bruising may 
occur following catheter placement and may result in mild-to-moderate soreness to the touch for 
several days. You will be exposed to a small amount of radiation from the DXA scan  that is 
equivalent to 1/10 the exposure from a routine chest x-ray, and less than the exposure from a 
dental x-ray. 
 
What are the potential benefits of doing this study? 
There is no direct benefit to you for participating in the study, except that you will receive 9 
supervised training sessions. 
 
Benefits gained by the researchers will be an increase in knowledge about the effect of sprint 
exercise training on hormonal and oxidative stress responses. 
 
How will your confidentiality be maintained? 
You will be assigned a subject number and all data will be identified by this number.  The list 
connecting your name to this number will be kept in a locked file. Your name will not be used in any 
report. All information that is obtained during this study will be accessible only to the research staff. 
All de-identified data will be stored on the principal investigator’s personal computer. 
 
What happens if you get injured during the study? 
There is no compensation for any physical injury that may result from your participation.   
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What happens if you have questions before or after you are involved in the study? 
The University of North Carolina at Greensboro Institutional Review Board, which ensures that 
research involving people follows federal regulations, has approved the research and this consent 
form.  Questions regarding your rights as a participant in this project can be answered by calling 
Mr. Eric Allen at (336) 256-1482.  Questions regarding the research itself will be answered by 
Laurie Wideman, PhD at 334-3234, Jason K. Smith at (704) 609-6367 or Kevin Ritsche at 473-
7293.  Any new information that develops during this project will be provided to you if the 
information might affect your willingness to continue participation in the project. 
 
What if you want to stop your participation in the study? 
You are free to refuse to participate or to withdraw your consent to participate in this research at 
any time without penalty or prejudice; your participation is entirely voluntary. 
 
What does signing this paper mean? 
By signing this consent form you agree that you understand exactly what we are asking you to do, 
how long it will take, and any risks and benefits involved in this research. 
 
By signing this form, you are affirming that you are 18 years of age or older and are agreeing to 
participate in the project described to you by ________________.  A copy of this consent form will 
be provided to you for your records. 
 
 
____________________________________   ______________ 
Participant's Signature       Date  
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APPENDIX C:  
 
PHYSICAL ACTIVITY QUESTIONNAIRE 
 
 
Physical Activity Questionnaire 
Fall 2008 
 
Name: ______________________  Date: __________________ 
 
 
 
 
Question #1: In general, compared to other persons your age, rate how physically fit 
you are: 
 
1  2 3 4 5 6 7 8 9 10 
 
Not at all fit    Somewhat fit    Extremely fit 
 
 
Question #2: How often do you engage in resistance training? 
 
□ 5 or more times per week     □ 4 times per week  □ 3 times per week  
□ 2 times per week            □ 1 time per week  □ Never/only occasionally 
 
Question #3: How much hard physical work is required on your job? 
□ a great deal   □ a moderate amount  □ a little □ none 
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APPENDIX D:  
 
MEDICAL QUESTIONNAIRE 
 
 
MEDICAL QUESTIONNAIRE 
 
The purpose of this questionnaire is to determine if you have any physical 
limitations that may exclude you from participation in this investigation.  All 
information will be kept completely confidential. 
 
A.  Personal Information 
Name/Last: _______________ First: ___________ Middle Initial: _______ 
Date of Birth: ___________ Gender: ________ 
Address/Street: ________________________________________________ 
City: _______________  State: ________    Zip Code: ________   
Phone (H): _________________ Phone (w): ________________ 
Phone (cell): ________________ E-mail: ___________________ 
Best way to reach you and when?_____________________________________ 
 
1. When was your last physical exam? ___________________ 
 
2. Please list any serious or chronic illnesses of which you are 
aware._______________________________________________________ 
 
3. Please list any allergies to medications, foods, or other substances. 
_____________________________________________________________ 
 
4.  Please list any medication you have been on or presently take 
Type    Dosage/Frequency How Long? Why? 
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B.  Medical History 
1.  Illnesses---Please check if you have had any of the following: 
Illness Present Past Dates 
Heart attack    
Anemia    
Asthma    
Epilepsy    
Lung disease    
Stroke    
Gout    
Diabetes    
Hypoglycemia    
Rheumatic fever    
Heart murmur    
Hernia    
 
 
2.  Symptoms---During the last 12 months, have you experienced: 
Condition Yes No 
High blood pressure   
Swelling of hands and feet   
Pain or cramps in legs   
Orthopedic problems   
Musculoskeletal problems   
ECG abnormalities   
Blurred vision   
Chest pain/pressure   
Shortness of breath   
Unusual fatigue   
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Dizziness/light headed   
Significant weight change   
High cholesterol   
Numbness in limbs or face   
 
3.  Hospitalizations---List the dates and the reasons for hospitalizations for any 
significant illness. 
  Date  Diagnosis 
1. 
2.  
3.  
 
C.  Family History 
1.  Is your father living? Yes___No___If not, age at death and cause. 
2.  Is your mother living? Yes___No___If not, age at death and cause. 
3.  Has you father, mother, grandparents, or siblings had:  
Condition Yes No Who? 
High blood pressure    
Stroke    
Heart attack (<50 yrs)    
Heart attack (>50 yrs)    
Diabetes    
Cardiovascular disease    
Other    
 
 
 
